ARCHIVES

Small Businesses Receive $18 Million From NCI Through SBIR Program

This article is from The Cancer Letter archive.

Vol. 18 No. 31 | July 31, 1992

Download PDF Visit The Full Archive

Related Articles

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

Block, Committee Agree; No New PDQ For General Public

January 11, 1985